Seeking Alpha

Immunogen (IMGN)

()

Instablog posts on IMGN

  • Channeling Mike Huckman: A Look at SABCS 2009 by R.J Steffens
     .Mike Huckman is CNBC's Pharmaceuticals Reporter covering the drug, biotechnology and medical device industries. Huckman runs a popular blog called "Pharma's Market" which appears at CNBC's website. Huckman's latest blog is titled Remember The Alamo Embargo and is his effort... More »
    December 13, 2009 ONXX, DNA, IMGN
  • RxNews Recap for Thursday 12-03-09 by M. E. Garza
    Below is a list of the healthcare sector companies that made news in the healthcare sector on Thursday, December 3, 2009. This list feature is meant to help investors keep tabs on the sector without having to scour through all the press releases.Access Pharmaceuticals, Inc., (OTC Bulletin... More »
    December 4, 2009 OVTI, SNTS, NVD
  • A Busy Month for Immunogen (Part II) by Ohad Hammer
    For part I click here At ASH 2009, Immunogen (IMGN) and its partners will present clinical data on three compounds: Sanofi-Aventis’ (SNY) SAR3419, Immunogen’s IMGN901 and Biotest’s BT-062.SAR3419 SAR3419 was originally developed by Immunogen, who out-licensed it to... More »
    December 2, 2009 IMGN, MITI, SGEN
  • December's Game Plan for Biotech by Justin M. Hall
    Historically, playing the drug makers in December has proven to be a safe bet. December ranks first, above August and September, as the best performing month for the iShares Nasdaq Biotechnology (IBB) ETF with average gains of about 8%.Outlined below is a game plan that might help investors... More »
    December 1, 2009 IBB, ENDP, SPPI
  • A Busy Month for Immunogen (Part I) by Ohad Hammer
      The month of December has always been a busy period for biotech investors, due to two important events:  The annual meeting of American Society of Hematology (ASH) and the San Antonio Breast Cancer Symposium (SABCS). Every year, these events produce clinical data that can... More »
    November 30, 2009 IMGN, SNY, GSK
  • Biotech Baker’s Dozen to Watch at Hematology Meeting by Michael Becker
    The 51st American Society of Hematology [ASH] Annual Meeting will take place December 5-8, 2009, at the Ernest N. Morial Convention Center in New Orleans, LA.  This is the premier event for the hematology industry, attracting more than 20,000 hematologists and other health-care... More »
    November 29, 2009 AEZS, ALTH, ARIA
  • Double Dip Investing by Justin M. Hall
    Market sentiment appears to be shifting. Many investors are becoming more pessimistic and anxious.  The term "Double Dip" is being repeated and recycled every 15 minutes (and sometimes less) on CNBC.  This sentiment is shared by investors, both... More »
    November 20, 2009 UUP, SPPI, ARIA
  • RxNews Recap for Tuesday 11-17-09 by M. E. Garza
    Below is a list of the healthcare sector companies that made news in the healthcare sector on Tuesday, November 18, 2009. This list feature is meant to help investors keep tabs on the sector without having to scour through all the press releases.Advaxis, Inc., (OTCBB: ADXS), the live, attenuated... More »
    November 18, 2009 AVNR, DARA, EXEL
  • Breakout Stocks on BIG Volume November 16, 2009 & RINO Detailed Option Trade by Marco Hickey
    Here is a tall list of stocks which traded higher Monday November 16, 2009 on unusually higher volume. When we have a move such as we did Monday, it is not unusual to see this many stocks moving higher on greater volume than the 50 day average. I will keep an eye on these stocks Tuesday to see... More »
    November 17, 2009 SPY, DIA, QQQQ
  • RxNews Recap for Wednesday 11-11-09 by M. E. Garza
    Below is a list of the healthcare sector companies that made news in the healthcare sector on Wednesday, November 11, 2009. This list feature is meant to help investors keep tabs on the sector without having to scour through all the press releases.AVANIR Pharmaceuticals, Inc. (NASDAQ:AVNR)... More »
    November 12, 2009 ALXN, CRIS, SNTA

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.